Are they Carbapenem-resistant (CRE) or Carbapenemase-producing (CPE) Enterobacteriaceae? Challenges of detection, differentiation and confirmation.

Robert Tibbets, Ph.D. D(ABMM), F(CCM)

Associate Director Microbiology Henry Health System, Detroit, MI

OBJECTIVES:

• Review the three main classes of beta lactamases in Gram Negatives: ESBLs, AmpCs, and Carbapenemases
• Review the differences between Carbapenem resistant Enterobacterales (CRE), carbapenemase-producing Carbapenem resistant Enterobacterales (CP-CRE), Carbapenem producing organisms and others
• Describe the challenges the lab faces based on these definitions and methods to confirm true CRE from CP-CRE

LEVEL OF INSTRUCTION:

INTERMEDIATE= Refresher course; some basic knowledge required

CE CONTACT HOURS:  1 hour

Clostridioides difficile Diagnostics

Paul Lephart, Ph.D. D(ABMM)

Associate Director, Clinical Microbiology Laboratory, Michigan Medicine/University of Michigan, Ann Arbor, MI

OBJECTIVES:

• Discuss the clinical significance of C. difficile disease
• Describe past and present algorithms for C. difficile testing
• Discuss C. difficile testing methodologies and test performance

LEVEL OF INSTRUCTION:

INTERMEDIATE= Refresher course; some basic knowledge required

CE CONTACT HOURS:  1 hour

New and Emerging Technology in Clinical Diagnostics

Daniel Ortiz, Ph.D. D(ABMM)

System Director, Microbiology, Beaumont Hospital, Royal Oak, MI

OBJECTIVES:

• Describe new or upcoming technology in clinical microbiology
• Compare and contrast old vs. new methodologies
• Evaluate clinical utility and feasibility of implementation

LEVEL OF INSTRUCTION:

INTERMEDIATE= Refresher course; some basic knowledge required

CE CONTACT HOURS:  1 hour

A Candid Conversation about Candida: What Your Laboratory Can Do to Help Stop the Spread of C. auris

Kimberly McCullor, Ph.D., MSc

Manager of Microbiology, Michigan Department of Health and Human Services Bureau of Laboratories, Lansing, MI

OBJECTIVES:

• Recognize best laboratory practices for the identification and surveillance of C. auris
• Identify public health resources available within Michigan and nationally to help slow the spread of C. auris within the state
• Become familiarized with the current prevalence of C. auris at the state, national and global level.

LEVEL OF INSTRUCTION:

BASIC= Entry level; no prior knowledge of subject necessary to attend this program

CE CONTACT HOURS:  1 hour

Case Studies: The Power of the Gram Stain in Clinical Diagnosis

Melphine Harriott, Ph.D. D(ABMM), MT(ASCP)SM^CM

Technical Director, Clinical Microbiology, Ascension Michigan Laboratory Services, Detroit, MI

OBJECTIVES:

• Recognize unusual organisms in Gram-stained smears
• Explain the clinical significance of the organisms discussed in today’s talk
• Discuss the significance of providing as much detailed information as possible when reporting direct Gram stains

LEVEL OF INSTRUCTION:

INTERMEDIATE= Refresher course; some basic knowledge required

CE CONTACT HOURS:  1 hour

Eric T Beck, PhD, D(ABMM)

SCACM State Director-
Wisconsin

from ACL Laboratories, West Allis, WI

Rhonda Graham

State Director-
Ohio

from The Ohio State University

Wexner Medical Center East Hospital,

Columbus, OH